Evidence map›Paper›PMID 31315600›Full record

Observational studyBMC pediatrics2019

Early Check: translational science at the intersection of public health and newborn screening.

Donald B Bailey, Lisa M Gehtland, Megan A Lewis, Holly Peay, Melissa Raspa, Scott M Shone, Jennifer L Taylor, Anne C Wheeler, Michael Cotten, Nancy M P King and 14 more

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in BMC pediatrics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03655223 (Early Check), which is not on this map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03655223 active not recruitingnot on this map

Early Check: A Collaborative Innovation to Facilitate Pre-Symptomatic Clinical Trials in Newborns

TypeobservationalSponsorRTI InternationalRan2018 to 2026Enrolled30,000ConditionsSpinal Muscular Atrophy, Fragile X Syndrome, Fragile X - Premutation, Duchenne Muscular DystrophyArmsConfirmatory Testing
3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Data-driven consideration of genetic disorders for global genomic newborn screening programs.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. A systematic framework for selecting gene-condition pairs for inclusion in newborn sequencing panels: Early Check implementation.Genetics in medicine : official journal of the American College of Medical Genetics · 2024
    Article
  13. Review
  14. Review
  15. When is the best time to screen and evaluate for treatable genetic disorders?: A lifespan perspective.American journal of medical genetics. Part C, Seminars in medical genetics · 2023
    Review
  16. Article
  17. Establishing the Medical Actionability of Genomic Variants.Annual review of genomics and human genetics · 2022
    Review
  18. Newborn screening research sponsored by the NIH: From diagnostic paradigms to precision therapeutics.American journal of medical genetics. Part C, Seminars in medical genetics · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Donald B BaileyCenter for Newborn Screening, Ethics, and Disability Studies, RTI International, 3040 E. Cornwallis Rd., Research Triangle Park, NC, 27709, USA. dbailey@rti.org.
Lisa M GehtlandCenter for Newborn Screening, Ethics, and Disability Studies, RTI International, 3040 E. Cornwallis Rd., Research Triangle Park, NC, 27709, USA.
Megan A LewisRTI International, Seattle, WA, USA.
Holly PeayCenter for Newborn Screening, Ethics, and Disability Studies, RTI International, 3040 E. Cornwallis Rd., Research Triangle Park, NC, 27709, USA.
Melissa RaspaCenter for Newborn Screening, Ethics, and Disability Studies, RTI International, 3040 E. Cornwallis Rd., Research Triangle Park, NC, 27709, USA.
Scott M ShoneCenter for Newborn Screening, Ethics, and Disability Studies, RTI International, 3040 E. Cornwallis Rd., Research Triangle Park, NC, 27709, USA.
Jennifer L TaylorCenter for Newborn Screening, Ethics, and Disability Studies, RTI International, 3040 E. Cornwallis Rd., Research Triangle Park, NC, 27709, USA.
Anne C WheelerCenter for Newborn Screening, Ethics, and Disability Studies, RTI International, 3040 E. Cornwallis Rd., Research Triangle Park, NC, 27709, USA.
Michael CottenDuke University, Durham, NC, USA.
Nancy M P KingWake Forest School of Medicine, Winston-Salem, NC, USA.
Cynthia M PowellUniversity of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
Barbara BieseckerRTI International, Washington, DC, USA.
Christine E BishopWake Forest School of Medicine, Winston-Salem, NC, USA.
Beth Lincoln BoyeaCenter for Newborn Screening, Ethics, and Disability Studies, RTI International, 3040 E. Cornwallis Rd., Research Triangle Park, NC, 27709, USA.
Martin DuparcCenter for Newborn Screening, Ethics, and Disability Studies, RTI International, 3040 E. Cornwallis Rd., Research Triangle Park, NC, 27709, USA.
Blake A HarperCenter for Newborn Screening, Ethics, and Disability Studies, RTI International, 3040 E. Cornwallis Rd., Research Triangle Park, NC, 27709, USA.
Alex R KemperNationwide Children's Hospital, Cincinnati, OH, USA.
Stacey N LeeCenter for Newborn Screening, Ethics, and Disability Studies, RTI International, 3040 E. Cornwallis Rd., Research Triangle Park, NC, 27709, USA.
Rebecca MoultrieRTI International, Chesterfield, MO, USA.
Katherine C OkoniewskiCenter for Newborn Screening, Ethics, and Disability Studies, RTI International, 3040 E. Cornwallis Rd., Research Triangle Park, NC, 27709, USA.
Ryan S PaquinRTI International, Minneapolis, MN, USA.
Denise PettitNorth Carolina State Laboratory of Public Health, Raleigh, NC, USA.
Katherine Ackerman PorterCenter for Newborn Screening, Ethics, and Disability Studies, RTI International, 3040 E. Cornwallis Rd., Research Triangle Park, NC, 27709, USA.
Scott J ZimmermanNorth Carolina State Laboratory of Public Health, Raleigh, NC, USA.

Funding

Re-Entry Supplement: Investigation of Oral Microbial Enzymes for the Detection and Treatment of Periodontal DiseaseUL1TR002489 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, SHAHEEN, NICHOLAS J · 2018 to 2022
$48.6M
North Carolina Translational & Clinical Sciences Institute (NC TraCS)UL1TR001111 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, CAREY, TIMOTHY S · 2013 to 2017
$43.9M
Wake Forest Clinical and Translational Science AwardUL1TR001420 · NCATS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ARD, JAMY D, FOLEY, KRISTIE L · 2015 to 2023
$32.3M
Early Check: A Collaborative Innovation to Facilitate Pre-Symptomatic Clinical Trials in NewbornsU01TR001792 · NCATS · RESEARCH TRIANGLE INSTITUTE · PI BAILEY, DONALD B, COTTEN, CHARLES MICHAEL · 2016 to 2020
$7.8M
Eunice Kennedy Shriver National Institute of Child Health and Human Development HHSN27500003NCATS NIH HHS U01 TR001792NCATS NIH HHS UL1 TR001111NCATS NIH HHS UL1 TR001420NCATS NIH HHS UL1 TR002489
6 · The paper itself

Abstract

backgroundNewborn screening (NBS) occupies a unique space at the intersection of translational science and public health. As the only truly population-based public health program in the United States, NBS offers the promise of making the successes of translational medicine available to every infant with a rare disorder that is difficult to diagnose clinically, but for which strong evidence indicates that presymptomatic treatment will substantially improve outcomes. Realistic NBS policy requires data, but rare disorders face a special challenge: Screening cannot be done without supportive data, but adequate data cannot be collected in the absence of large-scale screening. The magnitude and scale of research to provide this expanse of data require working with public health programs, but most do not have the resources or mandate to conduct research.

methodsTo address this gap, we have established Early Check, a research program in partnership with a state NBS program. Early Check provides the infrastructure needed to identify conditions for which there have been significant advances in treatment potential, but require a large-scale, population-based study to test benefits and risks, demonstrate feasibility, and inform NBS policy. DISCUSSION: Our goal is to prove the benefits of a program that can, when compared with current models, accelerate understanding of diseases and treatments, reduce the time needed to consider inclusion of appropriate conditions in the standard NBS panel, and accelerate future research on new NBS conditions, including clinical trials for investigational interventions.

trial registrationClinicaltrials.gov registration # NCT03655223 . Registered on August 31, 2018.

Indexed as

Neonatal ScreeningPublic HealthTranslational Research, BiomedicalEarly DiagnosisFemaleFollow-Up StudiesFragile X SyndromeHealth PolicyHumansInfant, NewbornInformed ConsentInternetIntersectoral CollaborationMaleMuscular Atrophy, SpinalNorth CarolinaNewborn screeningRare disordersTranslational science

Identifiers

PMID31315600
PMCPMC6636013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.